Avoro Capital Advisors LLC Top Holdings and 13F Report (2026) About Avoro Capital Advisors LLCInvestment ActivityAvoro Capital Advisors LLC has $9.69 billion in total holdings as of September 30, 2026.Avoro Capital Advisors LLC owns shares of 30 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 2.47% of the portfolio was purchased this quarter.About 3.75% of the portfolio was sold this quarter.This quarter, Avoro Capital Advisors LLC has purchased 26 new stocks and bought additional shares in 1 stock.Avoro Capital Advisors LLC sold shares of 15 stocks and completely divested from 1 stock this quarter.Largest Holdings United Therapeutics $1,493,207,699ASCENDIS PHARMA A/S $1,150,541,500Krystal Biotech $960,728,593argenex $958,910,000Madrigal Pharmaceuticals $923,926,499 Largest New Holdings this Quarter G2646Y104 - DAMORA THERAPEUTICS INC $80,502,240 Holding00370M103 - ABIVAX SA $48,321,760 Holding811033109 - SCRIBE THERAPEUTICS INC $47,834,098 HoldingG111OE107 - BIOHAVEN LTD $36,712,500 Holding10567X101 - BRAVEHEART BIO INC $25,351,000 Holding Largest Purchases this Quarter DAMORA THERAPEUTICS INC 3,783,000 shares (about $80.50M)ABIVAX SA 488,000 shares (about $48.32M)SCRIBE THERAPEUTICS INC 2,598,973 shares (about $47.83M)BIOHAVEN LTD 2,750,000 shares (about $36.71M)BRAVEHEART BIO INC 1,255,000 shares (about $25.35M) Largest Sales this Quarter Celcuity 1,900,000 shares (about $151.09M)Revolution Medicines 152,000 shares (about $31.20M)Arrowhead Pharmaceuticals 355,555 shares (about $23.27M)ASCENDIS PHARMA A/S 61,111 shares (about $13.92M)United Therapeutics 22,222 shares (about $12.04M) Sector Allocation Over TimeMap of 500 Largest Holdings ofAvoro Capital Advisors LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorUTHRUnited Therapeutics$1,493,207,699$12,041,880 ▼-0.8%2,755,55515.4%HealthcareASCENDIS PHARMA A/S$1,150,541,500$13,922,919 ▼-1.2%5,050,00011.9%ORDINARY SHARESKRYSKrystal Biotech$960,728,5930.0%2,888,8889.9%HealthcareARGXargenex$958,910,0000.0%1,000,0009.9%HealthcareMDGLMadrigal Pharmaceuticals$923,926,4990.0%1,833,3339.5%HealthcareKYMRKymera Therapeutics$835,601,9670.0%7,474,7478.6%HealthcareARWRArrowhead Pharmaceuticals$719,950,000$23,271,075 ▼-3.1%11,000,0007.4%HealthcareRVMDRevolution Medicines$440,282,700$31,199,520 ▼-6.6%2,145,0004.5%HealthcareCYTKCytokinetics$322,959,000$6,590,934 ▼-2.0%4,900,0003.3%HealthcareDEFINIUM THERAPEUTICS INC$268,323,000$5,286,077 ▼-1.9%7,050,0002.8%COMMONGPCRStructure Therapeutics$204,992,2050.0%6,555,5552.1%HealthcareXENEXenon Pharmaceuticals$204,545,000$10,330,527 ▼-4.8%5,500,0002.1%HealthcareVERAVera Therapeutics$181,954,150$2,870,194 ▼-1.6%5,635,0001.9%HealthcareQUREuniQure$162,543,0920.0%6,727,7771.7%HealthcareCELCCelcuity$119,280,000$151,088,000 ▼-55.9%1,500,0001.2%HealthcareTSHATaysha Gene Therapies$116,338,8850.0%23,888,8881.2%HealthcareOCULOcular Therapeutix$94,956,901$1,224,899 ▼-1.3%12,380,3001.0%HealthcareDAMORA THERAPEUTICS INC$80,502,240$80,502,240 ▲New Holding3,783,0000.8%COMMONHEMAB THERAPEUTICS HLDGS INC$58,360,752$1,010,874 ▼-1.7%1,892,3720.6%COMMONVRDNViridian Therapeutics$51,475,0000.0%2,500,0000.5%HealthcareSEPTERNA INC$50,869,000$1,467,375 ▼-2.8%1,300,0000.5%COMMONABIVAX SA$48,321,760$48,321,760 ▲New Holding488,0000.5%SPONSORED ADSSCRIBE THERAPEUTICS INC$47,834,098$47,834,098 ▲New Holding2,598,9730.5%COMMONFAETH THERAPEUTICS INC$41,933,400$1,012,320 ▼-2.4%1,410,0000.4%COMMONGHRSGH Research$41,559,600$704,400 ▼-1.7%1,770,0000.4%HealthcareBIOHAVEN LTD$36,712,500$36,712,500 ▲New Holding2,750,0000.4%COMMONAVALO THERAPEUTICS INC$36,451,321$681,327 ▲1.9%2,377,7770.4%COMMONBRAVEHEART BIO INC$25,351,000$25,351,000 ▲New Holding1,255,0000.3%COMMONAADIAadi Bioscience$10,713,7520.0%2,849,4020.1%HealthcareLEXEO THERAPEUTICS INC$1,774,500$3,258,959 ▼-64.7%525,0000.0%COMMONDAMORA THERAPEUTICS INC$0$98,395,830 ▼-100.0%00.0%CommonShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.